EP1177425A1 - Method and system for detecting trace materials in cryogenic liquids - Google Patents

Method and system for detecting trace materials in cryogenic liquids

Info

Publication number
EP1177425A1
EP1177425A1 EP00926451A EP00926451A EP1177425A1 EP 1177425 A1 EP1177425 A1 EP 1177425A1 EP 00926451 A EP00926451 A EP 00926451A EP 00926451 A EP00926451 A EP 00926451A EP 1177425 A1 EP1177425 A1 EP 1177425A1
Authority
EP
European Patent Office
Prior art keywords
cryogenic liquid
impurity
liquid sample
sample
absoφtion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00926451A
Other languages
German (de)
French (fr)
Inventor
Dwight Sherod Glaxo Wellcome Inc. WALKER
John Anderson Jr. Glaxo Wellcome Inc. MASCHO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of EP1177425A1 publication Critical patent/EP1177425A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/3577—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing liquids, e.g. polluted water
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N21/05—Flow-through cuvettes

Definitions

  • Th present invention relates generally to a system for detecting trace materials in cryogenic liquids. More particularly, the invention relates to a method and system for detecting trace amounts of a material or component in cryogenic liquids by means of infrared spectroscopic analysis.
  • cryogenic liquid is generally defined as a fluid which would be a vapor under ambient conditions of temperature and pressure.
  • Typical examples of cryogenic liquids include liquid oxygen, liquid nitrogen, liquid argon, liquid methane, liquid helium, liquid neon, liquid hydrogen and liquid fluorinated hydrocarbons (i.e., Freon' ).
  • Cryogenic liquids are employed in a variety of applications, such as coolants, cleaning agents and polymer transfer agents.
  • the inhalation formulation i.e., active ingredient
  • the inhalation formulation is typically carried to the patient in an aerosol propellant stream of chemically inert and biologically safe material.
  • the most commonly employed propellants are fluorinated hydrocarbons.
  • Cryogenic liquids are often produced by the cryogenic distillation of a feed, such as air, in a cryogenic distillation plant comprising one or more cryogenic distillation columns.
  • a feed such as air
  • samples of the cryogenic liquid must be routinely obtained and analyzed.
  • cryogenic liquids are transported from the production facility to the new site, generally in cylinders or tanker trucks.
  • the cryogenic liquids are then often stored at the use site in storage tanks.
  • additional samples of the cryogenic liquid are typically obtained and analyzed.
  • the propellant and inhalation formulation are introduced directly into a patient's lungs, it is absolutely imperative that the propellant be free of residual components and contaminants (i.e., impurities). Such materials generally arise during general maintenance and/or cleaning of the drug delivery lines. Thus, after maintenance and/or cleaning of the lines, the propellant must be analyzed to detect the presence of any trace materials.
  • One method of sampling a cryogenic liquid is the batch technique wherein a sample of the cryogenic liquid is caused to flow into a capture device or cell. The flow of cryogenic liquid is then shut off and the sample is warmed to produce a gas, which is passed on to one or more analyzers.
  • Typical analyzers include a gas chromatograph, a paramagnetic oxygen analyzer or an electro-chemical oxygen analyzer.
  • the batch method is disadvantageous for several reasons. First, a large amount of sample is vented and thus lost. Second, the batch capture system is complicated and costly. Third, and perhaps most important, the batch technique is inherently limited in timeliness of the information obtained.
  • Another method of sampling a cyrogenic liquid involves the coupling of an analyzer system to a cyrogenic liquid source via a conduit which is sufficiently long to enable the cryogenic liquid to vaporize prior to reaching the analyzer or analyzers. Two major problems arise with this continuous sampling method. First, the vaporization of the cyrogenic liquid in the conduit results in local pressure increases, which cause liquid to flow back out of the conduit and into the cyrogenic liquid source.
  • Another problem with the continuous method is that the requisite long conduit affords an opportunity for a significant amount of trace impurities within the sample to plate onto the inside surface of the conduit. Still further, the long conduit results in a long response time from the acquisition of the sample to the analysis itself.
  • the method of detecting a trace material in a cryogenic liquid in accordance with this invention comprises the steps of (i) measuring the abso ⁇ tion spectrum of the cryogenic liquid by passing light in the infrared region through the cryogenic liquid, said cryogenic liquid absorption spectrum having a first reference energy, (ii) measuring the abso ⁇ tion spectrum of at least one impurity alone by passing light in the infrared region through said impurity, (iii) passing a cryogenic liquid sample into a flow cell, wherein the maximum pressure drop of the cryogenic liquid sample across said flow cell is in the range of 0.5 to 5.0 lb./in.
  • the system of the invention comprises (i) source of cryogenic liquid sample, (ii) conduit means in flow communication with the source of cryogenic liquid sample for transferring the cryogenic liquid sample to a plurality of locations, (iii) at least one flow cell in flow communication with the conduit means, the flow cell being adapted to maintain a maximum pressure drop across the cell in the range of 0.5 to 5.0 lb./in.
  • analyzer means for respectively measuring the abso ⁇ tion intensity of the base cryogenic liquid, target impurity and cryogenic liquid sample by separately passing near infrared light through the base cryogenic liquid, impurity and cryogenic liquid sample, (v) means for comparing the abso ⁇ tion intensities of the base cryogenic liquid, impurity and cryogenic liquid sample to determine the presence of the impurity in the cryogenic liquid sample, and (vi) means for determining the concentration of the impurity.
  • FIGURE 1 is a schematic illustration of a pharmaceutical mixing and delivery system employing the sampling and analysis system of the present invention
  • FIGURE 2 is a partial section plan view of a mixing chamber and flow cell of the present invention.
  • FIGURE 3 is a plan view of a cryogenic liquid storage column employing the sampling system of the present invention
  • FIGURE 4 is a schematic illustration of a production facility employing an additional embodiment of the sampling and analysis system of the present invention.
  • FIGURE 5 are abso ⁇ tion curves for methanol measured in an embodiment of the present invention.
  • cryogenic liquid substantially reduces or eliminates the di .advantages and shortcomings associated with prior art cryogenic liquid sampling and analysis methods.
  • the present invention provides for simple, accurate and reliable continuous sampling and analysis of a cryogenic liquid to determine the presence and identity of trace components and/or contaminants.
  • cryogenic liquid as used herein, it is meant to mean a liquid that would be a vapor at a temperature of 15°-25°C at 1.0 atmosphere.
  • cryogenic liquid thus includes liquid oxygen, liquid nitrogen, liquid argon, liquid methane, liquid helium, liquid neon, liquid hydrogen, and liquid fluorinated hydrocarbons, including, hydrofluorocarbons, chlorofiuorocarbons, hydrofluoroalkanes and derivatives thereof.
  • components are meant to include (i) materials having vibration energies in the range of 3 x 10el4-12el4Hz, (ii) materials containing OH, CH, SH, CO and NH bonds and (iii) volatile organics.
  • the conventional cryogenic liquid sampling methods and systems have numerous drawbacks and/or disadvantages.
  • the methods and systems are generally complex, inherently limited in timeliness and limited in location of sampling (e.g., site).
  • applicant's method and system provides prompt, accurate data and is readily adaptable to any location (or multiple locations) within the production environment, including the cryogenic liquid delivery lines.
  • the mixing and delivery system 5 includes a cryogenic liquid (i.e., Freon ® ) reservoir 10 for containing the cryogenic liquid material 7, a cryogenic liquid feed line 12, a feed valve 14, a filling unit 16, a recirculation line 18, a mixing chamber 20, which facilitates mixing of the cryogenic liquid and the pharmaceutical formulation, and a pump 22.
  • a cryogenic liquid i.e., Freon ®
  • the sampling (and analysis) system 30 of the invention includes a flow cell 32 an analyzer 52 to determine the presence and identity of trace components and/or contaminants (i.e., impurities) in the cryogenic liquid 7 and processing means 54 to control the analyzer and process data therefrom.
  • the analyzer 52 comprises an infrared spectroscopic analyzer.
  • each trace material i.e., component and contaminant contained in the cryogenic liquid will exhibit a distinctive abso ⁇ tion spectrum.
  • the identity of a selective one of the trace materials i.e., target impurity
  • the abso ⁇ tion spectrum i.e., the wavelength of the light absorbed
  • Further analysis of the abso ⁇ tion spectra is achieved by virtue of the processing means 54 of the invention, which, in a preferred embodiment, comprises a computer.
  • the flow cell 32 of the invention is preferably in flow communication with the mixing chamber 20.
  • the flow cell 32 provides substantially uniform and continuous flow of the cryogenic liquid (with and without the pharmaceutical formulation) therethrough with a maximum pressure drop across the flow cell 32 in a range of 0.5 to 5.0 lb./in. 2 , preferably 0.75 to 1.5 lb./in. 2 . More preferably, the maximum pressure drop is approximately 1.0 lb./in. 2 .
  • the flow cell 32 is preferably constructed of copper, stainless steel, or another like material and is vacuum insulated to ensure that the cryogenic liquid 7 remains in its liquid state (i.e., does not vaporize).
  • the flow cell 32 includes cooling means (shown in phantom in Figure 2) comprising a cell liner 38 and control means 39 to control the temperature of the cryogenic liquid 7 within the flow cell 32.
  • the flow cell 32 further includes couplings 33, 34, which are adapted to receive a light source line 51 and analyzer line 53, respectively.
  • the couplings 33, 34 are further adapted to facilitate communication by and between (i) the light source line 51 and tungsten halogen lamp 35 and (ii) analyzer line 53 and analyzer probe 36, respectively.
  • an advantage of applicant's system is that the flow cell 32 and, hence, the system is readily adaptable to virtually any location of cryogenic liquid flow within a production environment. Such locations include pharmaceutical delivery lines, such as those illustrated in Figures 1 and 2, and a transfer line 42 proximate a storage tank or column 40, as illustrated in Figure 3.
  • multiple flow cells 32 may be disposed at various key locations within a production environment to provide random or continuous analysis of the cryogenic liquid.
  • FIG. 4 there is shown a schematic illustration of a simple production facility employing a multiple cell system of the invention.
  • the production facility is housed within a building structure 60 and includes a cryogenic liquid storage column 62, disposed externally of the building structure 60, a delivery line 64 (adapted to provide product, denoted by Arrow P), a valve 65, a plurality of pumps 66a, 66b in flow communication with the delivery line 64, a mixing chamber 68 and a component feed line 70 (adapted to feed a component into the mixing chamber 68, denoted by Arrow I).
  • the facility further includes a plurality of flow cells 32a, 32b and the light source 50, analyzer 52 and processing means 54 of the invention.
  • the light source 50 includes two light source lines 51a, 51b.
  • the light source lines 51a, 51b are in communication with cells 32a and 32b, respectively.
  • the analyzer 52 of the invention is similarly provided with two analyzer lines 53a, 53b.
  • the analyzer lines 53a, 53b are also in communication with cells 32a and 32b, respectively.
  • analyzer line 53c is directly connected to cell 32b and an additional processing means line 55a is employed.
  • data from each respective cell 32a, 32b is selectively acquired and processed by the processing means 54 of the invention, which is in communication with the analyzer 52 via processing means line 55 (or analyzers 52, 52a via processing means lines 55, 55a).
  • the analyzer 52 of the invention is adapted to determine the presence of trace components and contaminants in the cryogenic liquid.
  • the determination of a trace component or contaminant is preferably accomplished by conducting a first scan of the base cryogenic liquid to establish a first abso ⁇ tion spectrum having a first reference energy (i.e., abso ⁇ tion energy).
  • a second scan of at least one target material i.e., component or contaminant is then conducted to determine an impurity abso ⁇ tion spectrum associated with the target material.
  • the first and second scans preferably comprising near infrared light in the range of 900-2200 nanometers.
  • the first abso ⁇ tion spectrum and impurity abso ⁇ tion spectrum are then stored in the processing means 54 memory.
  • the cryogenic liquid sample is scanned while the sample is contained in a selected cell (i.e., J7, 32a, 32b) to obtain the sample abso ⁇ tion spectra.
  • the sample abso ⁇ tion spectra are then compared to the stored abso ⁇ tion spectra via the processing means 54 to distinguish among and confirm the presence of the cryogenic liquid sample abso ⁇ tion spectrum associated with the target material, the sample abso ⁇ tion spectrum associated with the impurity having a second reference energy.
  • the method thus provides accurate and reliable identification of a trace material in a cryogenic liquid sample.
  • further analysis and/or processing of the stored abso ⁇ tion spectra and the sample abso ⁇ tion spectra is provided by the processing means 54 of the invention.
  • additional analysis includes a determination of the concentration of the component or contaminant, and component and contaminant concentra ⁇ on profile(s) at selected cell locations.
  • E, reference energy (i.e., abso ⁇ tion energy) of the base cryogenic liquid abso ⁇ tion spectrum
  • E 2 reference energy of the sample abso ⁇ tion spectrum associated with the target material
  • Freon ® a sample of Freon ® was spiked with known concentrations of methanol.
  • Methanol an organic solvent, is typically employed to flush pharmaceutical filling lines between different product runs.
  • the solutions were then introduced into the mixing chamber 20 and ultimately into the flow cell 32.
  • NLR Near infrared light
  • the results of the trace determination experiment further indicate that trace amounts of an impurity — component and/or contaminant — can be accurately detected and quantified "on-line” at levels well below the pharmaceutical industry standard of ⁇ 0.02%.
  • the results were also achieved in a fraction of the time generally required for prior methods and systems.

Landscapes

  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Optical Measuring Cells (AREA)

Abstract

A method for qualitative and quantitative determination of trace impurities in a cryogenic liquid, comprising the steps of (i) measuring the absorption spectrum of the cryogenic liquid by passing light in the infrared region through the cryogenic liquid, the cryogenic liquid absorption spectrum having a first reference energy, (ii) measuring the absorption spectrum of at least one impurity alone by passing light in the infrared region through the impurity, (iii) passing a cryogenic liquid sample into a flow cell, wherein the maximum pressure drop of the cryogenic liquid sample across said flow cell is in the range of 0.5 to 5.0 lb./in.<2>, (iv) measuring the absorption spectra of the cryogenic liquid sample by passing light in the infrared region through the cryogenic liquid sample while the cryogenic liquid sample is within the cell, (v) comparing the cryogenic liquid sample absorption spectra to the cryogenic liquid and impurity spectra, (vi) confirming the presence of the sample absorption spectrum associated with the impurity, the sample absorption spectrum associated with the impurity having a second reference energy, and (vii) determining the concentration (C) of the impurity in the cryogenic liquid sample by the following relationship, kC = log second reference energy/first reference energy where k is a fixed proportionality constant.

Description

METHOD AND SYSTEM FOR DETECTING TRACE MATERIALS IN CRYOGENIC LIQUIDS
FIELD OF THE PRESENT INVENTION
Th present invention relates generally to a system for detecting trace materials in cryogenic liquids. More particularly, the invention relates to a method and system for detecting trace amounts of a material or component in cryogenic liquids by means of infrared spectroscopic analysis.
BACKGROUND OF THE INVENTION
A "cryogenic liquid" is generally defined as a fluid which would be a vapor under ambient conditions of temperature and pressure. Typical examples of cryogenic liquids include liquid oxygen, liquid nitrogen, liquid argon, liquid methane, liquid helium, liquid neon, liquid hydrogen and liquid fluorinated hydrocarbons (i.e., Freon' ).
Cryogenic liquids are employed in a variety of applications, such as coolants, cleaning agents and polymer transfer agents. In pharmaceutical inhalation systems, the inhalation formulation (i.e., active ingredient) is typically carried to the patient in an aerosol propellant stream of chemically inert and biologically safe material. The most commonly employed propellants are fluorinated hydrocarbons.
Cryogenic liquids are often produced by the cryogenic distillation of a feed, such as air, in a cryogenic distillation plant comprising one or more cryogenic distillation columns. In order to ensure that the plant is operating properly and also to ensure that product of requisite purity is being produced, samples of the cryogenic liquid must be routinely obtained and analyzed.
After production, the cryogenic liquids are transported from the production facility to the new site, generally in cylinders or tanker trucks. The cryogenic liquids are then often stored at the use site in storage tanks. In order to ensure that the cryogenic liquid has not been contaminated in transportation and/or storage, additional samples of the cryogenic liquid are typically obtained and analyzed.
Further, in the event of a cryogenic liquid being employed as a pharmaceutical propellant, since the propellant and inhalation formulation are introduced directly into a patient's lungs, it is absolutely imperative that the propellant be free of residual components and contaminants (i.e., impurities). Such materials generally arise during general maintenance and/or cleaning of the drug delivery lines. Thus, after maintenance and/or cleaning of the lines, the propellant must be analyzed to detect the presence of any trace materials.
Various methods (and systems) have been employed to ensure that a cryogenic liquid is free of residual components or contaminants. However, as discussed below, the conventional methods have several drawbacks and/or disadvantages.
One method of sampling a cryogenic liquid is the batch technique wherein a sample of the cryogenic liquid is caused to flow into a capture device or cell. The flow of cryogenic liquid is then shut off and the sample is warmed to produce a gas, which is passed on to one or more analyzers. Typical analyzers include a gas chromatograph, a paramagnetic oxygen analyzer or an electro-chemical oxygen analyzer.
The batch method is disadvantageous for several reasons. First, a large amount of sample is vented and thus lost. Second, the batch capture system is complicated and costly. Third, and perhaps most important, the batch technique is inherently limited in timeliness of the information obtained. Another method of sampling a cyrogenic liquid involves the coupling of an analyzer system to a cyrogenic liquid source via a conduit which is sufficiently long to enable the cryogenic liquid to vaporize prior to reaching the analyzer or analyzers. Two major problems arise with this continuous sampling method. First, the vaporization of the cyrogenic liquid in the conduit results in local pressure increases, which cause liquid to flow back out of the conduit and into the cyrogenic liquid source.
Another problem with the continuous method is that the requisite long conduit affords an opportunity for a significant amount of trace impurities within the sample to plate onto the inside surface of the conduit. Still further, the long conduit results in a long response time from the acquisition of the sample to the analysis itself.
It is therefore an object of the present invention to provide an improved method and system for sampling cryogenic liquids.
It is another object of the present invention to provide a simple, accurate and reliable method of detecting trace materials in cryogenic liquids.
It is another object of the invention to provide a method and system for detecting trace materials in cryogenic liquids at multiple locations within a production environment.
It is yet another object of the invention to provide a method of continuous sampling and analyzing of a cyrogenic liquid by means of near infrared spectroscopy.
SUMMARY OF THE INVENTION
In accordance with the above objects and those that will be mentioned and will become apparent below, the method of detecting a trace material in a cryogenic liquid in accordance with this invention comprises the steps of (i) measuring the absoφtion spectrum of the cryogenic liquid by passing light in the infrared region through the cryogenic liquid, said cryogenic liquid absorption spectrum having a first reference energy, (ii) measuring the absoφtion spectrum of at least one impurity alone by passing light in the infrared region through said impurity, (iii) passing a cryogenic liquid sample into a flow cell, wherein the maximum pressure drop of the cryogenic liquid sample across said flow cell is in the range of 0.5 to 5.0 lb./in.2, (iv) measuring the absoφtion spectra of the cryogenic liquid sample by passing light in the infrared region through the cryogenic liquid sample while the cryogenic liquid sample is within the cell, (v) comparing the cryogenic liquid sample absoφtion spectra to the cryogenic liquid and impurity spectra, (vi) confirming the presence of the sample absoφtion spectrum associated with the impurity, the sample absoφtion spectrum associated with the impurity having a second reference energy, and (vii) determining the concentration (C) of said impurity in the cryogenic liquid sample by the following relationship, kC = log second reference energy first reference energy
where k is a fixed proportionality constant.
The system of the invention comprises (i) source of cryogenic liquid sample, (ii) conduit means in flow communication with the source of cryogenic liquid sample for transferring the cryogenic liquid sample to a plurality of locations, (iii) at least one flow cell in flow communication with the conduit means, the flow cell being adapted to maintain a maximum pressure drop across the cell in the range of 0.5 to 5.0 lb./in.2, (iv) analyzer means for respectively measuring the absoφtion intensity of the base cryogenic liquid, target impurity and cryogenic liquid sample by separately passing near infrared light through the base cryogenic liquid, impurity and cryogenic liquid sample, (v) means for comparing the absoφtion intensities of the base cryogenic liquid, impurity and cryogenic liquid sample to determine the presence of the impurity in the cryogenic liquid sample, and (vi) means for determining the concentration of the impurity.
BRIEF DESCRIPTION OF THE DRAWINGS Further features and advantages will become apparent from the following and more particular description of the preferred embodiments of the invention, as illustrated in the accompanying drawings, and in which like referenced characters generally refer to the same parts or elements throughout the views, and in which:
FIGURE 1 is a schematic illustration of a pharmaceutical mixing and delivery system employing the sampling and analysis system of the present invention;
FIGURE 2 is a partial section plan view of a mixing chamber and flow cell of the present invention;
FIGURE 3 is a plan view of a cryogenic liquid storage column employing the sampling system of the present invention;
FIGURE 4 is a schematic illustration of a production facility employing an additional embodiment of the sampling and analysis system of the present invention; and
FIGURE 5 are absoφtion curves for methanol measured in an embodiment of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
The present invention substantially reduces or eliminates the di .advantages and shortcomings associated with prior art cryogenic liquid sampling and analysis methods. As discussed in detail below, the present invention provides for simple, accurate and reliable continuous sampling and analysis of a cryogenic liquid to determine the presence and identity of trace components and/or contaminants. By the term "cryogenic liquid", as used herein, it is meant to mean a liquid that would be a vapor at a temperature of 15°-25°C at 1.0 atmosphere. The term "cryogenic liquid" thus includes liquid oxygen, liquid nitrogen, liquid argon, liquid methane, liquid helium, liquid neon, liquid hydrogen, and liquid fluorinated hydrocarbons, including, hydrofluorocarbons, chlorofiuorocarbons, hydrofluoroalkanes and derivatives thereof.
The terms "components", "contaminants" and "impurities", as used herein, are meant to include (i) materials having vibration energies in the range of 3 x 10el4-12el4Hz, (ii) materials containing OH, CH, SH, CO and NH bonds and (iii) volatile organics.
As indicated above, the conventional cryogenic liquid sampling methods and systems have numerous drawbacks and/or disadvantages. The methods and systems are generally complex, inherently limited in timeliness and limited in location of sampling (e.g., site). In contrast to the conventional systems, applicant's method and system provides prompt, accurate data and is readily adaptable to any location (or multiple locations) within the production environment, including the cryogenic liquid delivery lines.
Referring to Figure 1, there is shown a simplified representation of a pharmaceutical mixing and delivery system 5 employing the sampling system 30 of the present invention. The mixing and delivery system 5 includes a cryogenic liquid (i.e., Freon®) reservoir 10 for containing the cryogenic liquid material 7, a cryogenic liquid feed line 12, a feed valve 14, a filling unit 16, a recirculation line 18, a mixing chamber 20, which facilitates mixing of the cryogenic liquid and the pharmaceutical formulation, and a pump 22.
The sampling (and analysis) system 30 of the invention includes a flow cell 32 an analyzer 52 to determine the presence and identity of trace components and/or contaminants (i.e., impurities) in the cryogenic liquid 7 and processing means 54 to control the analyzer and process data therefrom. In a preferred embodiment, the analyzer 52 comprises an infrared spectroscopic analyzer.
It is well known that when the molecules are exposed to electromagnetic rays (i.e., infrared light) of a wavelength which has a photon energy equivalent to their value of the vibration energy level, the molecules absorb the electromagnetic waves as their own vibration energy. The amount of absbφtion is proportionate to the abundance of the molecules present. When this vibration energy level value is converted to photon energy, ordinarily, it will correspond to wavelengths in the infrared region.
Accordingly, as discussed in detail below, when infrared light from the light source 50 is passed through the cryogenic liquid 7 (i.e., sample) within the flow cell 32 (see Fig. 2), each trace material (i.e., component and contaminant) contained in the cryogenic liquid will exhibit a distinctive absoφtion spectrum. The identity of a selective one of the trace materials (i.e., target impurity) is then determined from the absoφtion spectrum (i.e., the wavelength of the light absorbed) associated with the target impurity. Further analysis of the absoφtion spectra (e.g., quantitative determination) is achieved by virtue of the processing means 54 of the invention, which, in a preferred embodiment, comprises a computer.
Referring back to Figure 1, the flow cell 32 of the invention is preferably in flow communication with the mixing chamber 20. According to the invention, the flow cell 32 provides substantially uniform and continuous flow of the cryogenic liquid (with and without the pharmaceutical formulation) therethrough with a maximum pressure drop across the flow cell 32 in a range of 0.5 to 5.0 lb./in.2, preferably 0.75 to 1.5 lb./in.2. More preferably, the maximum pressure drop is approximately 1.0 lb./in.2.
According to the invention, the flow cell 32 is preferably constructed of copper, stainless steel, or another like material and is vacuum insulated to ensure that the cryogenic liquid 7 remains in its liquid state (i.e., does not vaporize). In additional envisioned embodiments, the flow cell 32 includes cooling means (shown in phantom in Figure 2) comprising a cell liner 38 and control means 39 to control the temperature of the cryogenic liquid 7 within the flow cell 32.
As illustrated in Figures 1 and 2, the flow cell 32 further includes couplings 33, 34, which are adapted to receive a light source line 51 and analyzer line 53, respectively. The couplings 33, 34 are further adapted to facilitate communication by and between (i) the light source line 51 and tungsten halogen lamp 35 and (ii) analyzer line 53 and analyzer probe 36, respectively. As indicated above, an advantage of applicant's system is that the flow cell 32 and, hence, the system is readily adaptable to virtually any location of cryogenic liquid flow within a production environment. Such locations include pharmaceutical delivery lines, such as those illustrated in Figures 1 and 2, and a transfer line 42 proximate a storage tank or column 40, as illustrated in Figure 3. Thus, multiple flow cells 32 may be disposed at various key locations within a production environment to provide random or continuous analysis of the cryogenic liquid.
Referring to Figure 4, there is shown a schematic illustration of a simple production facility employing a multiple cell system of the invention. The production facility is housed within a building structure 60 and includes a cryogenic liquid storage column 62, disposed externally of the building structure 60, a delivery line 64 (adapted to provide product, denoted by Arrow P), a valve 65, a plurality of pumps 66a, 66b in flow communication with the delivery line 64, a mixing chamber 68 and a component feed line 70 (adapted to feed a component into the mixing chamber 68, denoted by Arrow I). The facility further includes a plurality of flow cells 32a, 32b and the light source 50, analyzer 52 and processing means 54 of the invention.
In the noted embodiment, the light source 50 includes two light source lines 51a, 51b. The light source lines 51a, 51b are in communication with cells 32a and 32b, respectively.
The analyzer 52 of the invention is similarly provided with two analyzer lines 53a, 53b. The analyzer lines 53a, 53b are also in communication with cells 32a and 32b, respectively.
In additional envisioned embodiments, a plurality of analyzers 52, 52a (shown in phantom) are employed. In this embodiment, analyzer line 53c is directly connected to cell 32b and an additional processing means line 55a is employed.
According to the invention, data from each respective cell 32a, 32b (i.e., location) is selectively acquired and processed by the processing means 54 of the invention, which is in communication with the analyzer 52 via processing means line 55 (or analyzers 52, 52a via processing means lines 55, 55a).
As stated above, the analyzer 52 of the invention is adapted to determine the presence of trace components and contaminants in the cryogenic liquid. According to the invention, the determination of a trace component or contaminant is preferably accomplished by conducting a first scan of the base cryogenic liquid to establish a first absoφtion spectrum having a first reference energy (i.e., absoφtion energy). A second scan of at least one target material (i.e., component or contaminant) is then conducted to determine an impurity absoφtion spectrum associated with the target material. The first and second scans preferably comprising near infrared light in the range of 900-2200 nanometers.
The first absoφtion spectrum and impurity absoφtion spectrum (or spectra) are then stored in the processing means 54 memory. During on-line analysis, the cryogenic liquid sample is scanned while the sample is contained in a selected cell (i.e., J7, 32a, 32b) to obtain the sample absoφtion spectra. The sample absoφtion spectra are then compared to the stored absoφtion spectra via the processing means 54 to distinguish among and confirm the presence of the cryogenic liquid sample absoφtion spectrum associated with the target material, the sample absoφtion spectrum associated with the impurity having a second reference energy. The method thus provides accurate and reliable identification of a trace material in a cryogenic liquid sample.
According to the invention, further analysis and/or processing of the stored absoφtion spectra and the sample absoφtion spectra is provided by the processing means 54 of the invention. Such additional analysis includes a determination of the concentration of the component or contaminant, and component and contaminant concentraαon profile(s) at selected cell locations.
The concentration (C) of the component or contaminant is preferably determined as follows: kC = log E2 E, where:
E, = reference energy (i.e., absoφtion energy) of the base cryogenic liquid absoφtion spectrum;
E2 = reference energy of the sample absoφtion spectrum associated with the target material; and
k = fixed proportionality constant.
To demonstrate the superior performance of applicant's method and system, a sample of Freon® was spiked with known concentrations of methanol. Methanol, an organic solvent, is typically employed to flush pharmaceutical filling lines between different product runs.
The solutions were then introduced into the mixing chamber 20 and ultimately into the flow cell 32.
Near infrared light (NLR) in the range of 900-2200 nanometers was then passed through the sample within the flow cell 32. The resultant infrared absoφtion spectra (i.e., absoφtion curves), which were obtained using a Rosemount Analytical AOTF-NIR analyzer, are shown in Figure 5.
As illustrated in Figure 5, methanol and, hence, impurity concentrations of less than 0.01% are readily detected, distinguished and determined by the method and system of the invention. Such sensitivity in "in-situ" liquid analysis is unparalleled in the art.
The results of the trace determination experiment further indicate that trace amounts of an impurity — component and/or contaminant — can be accurately detected and quantified "on-line" at levels well below the pharmaceutical industry standard of < 0.02%. The results were also achieved in a fraction of the time generally required for prior methods and systems.
Without departing from the spirit and scope of this invention, one of ordinary skill can make various changes and modifications to the invention to adapt it to various usages and conditions. As such, these changes and modifications are properly, equitably, and intended to be, within the full range of equivalence of the following claims.

Claims

CLAIMS What is Claimed is:
1. A method for identifying impurities in a cryogenic liquid, comprising the steps of:
measuring the absoφtion spectrum of the cryogenic liquid;
measuring the absoφtion spectrum of at least one impurity alone;
passing a cryogenic liquid sample into a flow cell;
measuring the absoφtion spectra of said cryogenic liquid sample while said cryogenic liquid sample is within said cell;
comparing said cryogenic liquid sample absoφtion spectra to said cryogenic liquid and impurity spectra; and
confirming the presence of said sample absoφtion spectrum associated with said impurity.
2. The method of Claim 1 , wherein maximum pressure drop across said flow cell is in r.hc rarge of 0.5 to 5.0 lb./in.2.
3. The method of Claim 2, wherein said maximum pressure drop across said flow cell is in the range of 0.75 to 1.5 lb./in.2.
4. The method of Claim 1 , wherein said absoφtion spectra of said cryogenic liquid, impurity and cryogenic liquid sample is measured by passing light in the infrared region through said cryogenic liquid, impurity and cryogenic liquid sample.
5. The method of Claim 4, wherein said light to be passed through said cryogenic liquid, impurity and cryogenic liquid sample is scanned in the range of 900 to 2200 nanometers.
6. The method of Claim 1, wherein said cryogenic liquid comprises a liquid fluorinated hydrocarbon selected from the group consisting of a hydro fluorocarbon, chlorofluorocarbon, hydrofluoroalkane and derivatives thereof.
7. The method of Claim 1 , wherein said impurity comprises a material having at least a CO, NH, OH, CH and SH bond.
8. The method of Claim 1 , wherein said impurity comprises a material having a vibration energy in the range of approximately 3 x 1 Oe 14- 12e 14Hz.
9. The method of Claim 1 , wherein said impurity comprises a volatile organic.
10. A method for identifying impurities in a cryogenic liquid, comprising the steps of:
measuring the absoφtion spectrum of the cryogenic liquid by passing light in the infrared region through the cryogenic liquid, said cryogenic liquid absoφtion spectrum having a first reference energy;
measuring the absoφtion spectrum of at least one impurity alone by passing light in the infrared region through said impurity;
passing a cryogenic liquid sample into a flow cell, wherein the maximum pressure drop of said cryogenic liquid sample across said flow cell is in the range of 0.75 to
1.5 lb/in.2;
measuring the absoφtion spectra of said cryogenic liquid sample by passing light in the infrared region through said cryogenic liquid sample while said cryogenic liquid sample is within said cell; comparing said cryogenic liquid sample absoφtion spectra to said cryogenic liquid and impurity spectra;
confirming the presence of said cryogenic liquid sample absoφtion spectrum associated with said impurity, said sample absoφtion spectrum associated with said impurity having a second reference energy; and
determining the concentration (C) of said impurity in said cryogenic liquid sample by the following relationship, kC = log second reference energy first reference energy
where k is a fixed proportionality constant.
11. The method of Claim 10, wherein said flow cell provides substantially continuous flow of said cryogenic liquid sample through said flow cell.
12. The method of Claim 10, wherein said maximum pressure drop across said flow cell is approximately 1.0 lb./in.2.
13. The method of Claim 10, wherein said light to be passed through said cryogenic liquid, impurity and cryogenic liquid sample is scanned in the range of 900 to 2200 nanometers.
14. The method of Claim 10, wherein said cryogenic liquid comprises a liquid fluoπn-ije hydrocarbon selected from the group consisting of a hydro fi iorocarbon, chlorofluorocarbon, hydrofluoroalkane and derivatives thereof.
15. The method of Claim 10, wherein said impurity comprises a material having at least a CO, NH, OH, CH and SH bond.
16. The method of Claim 10, wherein said impurity comprises a material having a vibration energy in the range of approximately 3 x 10el4-12el4Hz.
17. The method of Claim 10, wherein said impurity comprises a volatile organic.
18. A method for identifying impurities in a cryogenic liquid at multiple locations within a production environment, comprising:
measuring the absoφtion spectrum of the cryogenic liquid by passing light in the infrared region through said cryogenic liquid, said cryogenic liquid absoφtion spectrum having a first reference energy;
measuring the absoφtion spectrum of at least one impurity alone by passing light in the infrared region through said impurity;
passing a cryogenic liquid sample into each of a plurality of flow cells, wherein the maximum pressure drop of said samples across said flow cells is in the range 0.5 to 5.0 lb./in.2, each of said flow cells corresponding to a location within the production environment;
selectively measuring the absoφtion spectra of said cryogenic liquid samples by passing light in the infrared region through said cryogenic liquid samples while said samples are contained within flow cells;
comparing said cryogenic liquid sample absoφtion spectra to said cryogenic liquid and impurity spectra;
confirming the presence of said sample absoφtion spectrum associated with said impurity, said sample absoφtion spectrum associated with said impurity having a second reference energy; and
determining the concentration (C) of said impurity in said cryogenic liquid sample at each of said cell locations by the following relationship,
kC = log second reference energy first reference energy where k is a fixed proportionality constant.
19. The method of Claim 18, wherein maximum pressure drop across said flow cells is in the range of 0.75 to 1.5 lb./in.2.
20. The method of Claim 18, wherein said maximum pressure drop across said flow cells is approximately 1.0 lb./in.2.
21. The method of Claim 18, wherein said light to be passed through said cryogenic liquid, impurity and cryogenic liquid samples is scanned in the range of 900 to 2200 nanometers.
22. The method of Claim 18, wherein said cryogenic liquid comprises a liquid fluorinated hydrocarbon selected from the group consisting of a hydro fluorocarbon, chlorofluorocarbon, hydrofluoroalkane and derivatives thereof.
23. The method of Claim 18, wherein said impurity comprises a material having at least a CO, NH, OH, CH and SH bond.
24. The method of Claim 18, wherein said impurity comprises a material having a vibration energy in the range of approximately 3 x 10el4-12el4Hz.
25. The method of Claim 18, wherein said impurity comprises a volatile organic.
26. A system for sampling a plurality of cryogenic liquid samples having a cryogenic liquid base, comprising:
a source of cryogenic liquid sample;
conduit means in flow communication with said source of cryogenic liquid sample for transferring said cryogenic liquid sample to a plurality of locations; at least one flow cell in communication with said conduit means, said flow cell adapted to maintain a maximum pressure drop across said cell in the range of 0.5 to 5.0 lb./in.2;
analyzer means for respectively measuring the absoφtion intensity of the base cryogenic liquid, target impurity and cryogenic liquid sample by separately passing infrared light through the base cryogenic liquid, impurity and cryogenic liquid sample; and
means for determining the concentration of said impurity.
27. The system of Claim 26, wherein said maximum pressu..^ drop across said cell is in the range of 0.75 to 1.5 lb./in.2.
28. The system of Claim 26, wherein said system comprises a plurality of flow cells.
29. The system of Claim 28, wherein said system includes control means in communication with said analyzer means to direct said analyzer means to conduct said measurement of said cryogenic liquid sample proximate a respective one of said flow cells.
EP00926451A 1999-04-30 2000-04-28 Method and system for detecting trace materials in cryogenic liquids Withdrawn EP1177425A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13204299P 1999-04-30 1999-04-30
US132042P 1999-04-30
PCT/US2000/011418 WO2000067000A1 (en) 1999-04-30 2000-04-28 Method and system for detecting trace materials in cryogenic liquids

Publications (1)

Publication Number Publication Date
EP1177425A1 true EP1177425A1 (en) 2002-02-06

Family

ID=22452180

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00926451A Withdrawn EP1177425A1 (en) 1999-04-30 2000-04-28 Method and system for detecting trace materials in cryogenic liquids

Country Status (4)

Country Link
EP (1) EP1177425A1 (en)
JP (1) JP2002543419A (en)
AU (1) AU4497800A (en)
WO (1) WO2000067000A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114460036A (en) * 2021-12-01 2022-05-10 西安航天动力试验技术研究所 System and method for detecting redundant substances in low-temperature medium supply system
US12366537B2 (en) * 2023-01-23 2025-07-22 GM Global Technology Operations LLC Vehicle coolant systems

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220510A (en) * 1978-07-13 1980-09-02 Massachusetts Institute Of Technology Method for separating isotopes in the liquid phase at cryogenic temperature
US4264814A (en) * 1979-07-31 1981-04-28 The United States Of America As Represented By The United States Department Of Energy Method for detecting trace impurities in gases
IT1236236B (en) * 1989-10-24 1993-01-27 Eridania DEVICE FOR COMPARATIVE ANALYSIS OF ORGANIC SAMPLES
US5457528A (en) * 1993-03-29 1995-10-10 Tobias; Reginald Identification and quantificaation of refrigerants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0067000A1 *

Also Published As

Publication number Publication date
WO2000067000A1 (en) 2000-11-09
AU4497800A (en) 2000-11-17
JP2002543419A (en) 2002-12-17

Similar Documents

Publication Publication Date Title
Cheng et al. Studies on repository compound stability in DMSO under various conditions
Zwank et al. Simultaneous determination of fuel oxygenates and BTEX using direct aqueous injection gas chromatography mass spectrometry (DAI-GC/MS)
EP2583083B1 (en) Method for replicating liquid blends and identifying the ratios of their liquid ingredients
Capdeville et al. Trace-level analysis of organic contaminants in drinking waters and groundwaters
Mitra et al. Sample preparation: an analytical perspective
Dewulf et al. Developments in the analysis of volatile halogenated compounds
US20140311220A1 (en) System and Method of Quantifying Impurities Mixed within a Sample of Hydrogen Gas
Wise et al. Review of direct MS analysis of environmental samples
Hangartner et al. Evaluation of passive methods for measuring ozone in the European Alps
US5191786A (en) Method for detecting the presence and concentration of relatively low molecular weight components in a liquid
EP1177425A1 (en) Method and system for detecting trace materials in cryogenic liquids
CN1241009C (en) In-situ monitoring method and apparatus for ultracritical fluid technology condition
RU2300101C2 (en) Evaluator for the quick self-acting analysis of the share of the acetaldehyde in the products made out of the polyethylene terephthalate, in particular, in the pressed bars and the method of its operation
Boaventura et al. Multivessel system for cold-vapor mercury generation determination of mercury in hair and fish
Tulchinsky et al. A practical portable HPLC system—MINICHROM, a new generation for field HPLC
Tena et al. Screening of polycyclic aromatic hydrocarbons in soil by on-line fiber-optic-interfaced supercritical fluid extraction spectrofluorometry
Yusop Nurida et al. Monitoring of CO2 Absorption Solvent in Natural Gas Process Using Fourier Transform Near‐Infrared Spectrometry
Holmes et al. Total organic carbon method for aspirin cleaning validation
US4838098A (en) Contained radiological analytical chemistry module
Gallagher et al. Performance of the HPLC/fluorescence SO2 detector during the GASIE instrument intercomparison experiment
Wright et al. Evaluation of a Field-Portable Supercritical Fluid Extraction Apparatus for Rapid Characterization of Contaminated Soils
US4909065A (en) Contained radiological analytical chemistry module
CA2854357A1 (en) Method to determine the dra in a hydrocarbon fuel
Thompson et al. Quantification of volatile organics in soil aging experiments using fourier transform infrared spectroscopy
KR100764838B1 (en) Appearance Analysis Apparatus and Properties Analysis Method of High Purity Terephthalic Acid Wastewater

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011019

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20040316

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: METHOD FOR DETECTING TRACE MATERIALS IN CRYOGENIC LIQUIDS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051024